¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"adrenal hyperplasia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypothalamic-pituitary-adrenal axis
    ½Ã»óÇϺÎ-³úÇϼöü-ºÎ½ÅÃà
  • angiolymphoid hyperplasia
    Ç÷°ü¸²ÇÁ±¸°ú´ÙÇü¼º, Ç÷°ü¸²ÇÁ±¸Áõ½Ä
  • atypical adenomatous hyperplasia
    ºñÁ¤Çü»ùÁ¾Áõ½Ä
  • atypical complex hyperplasia
    ºñÁ¤Çüº¹ÇÕÀڱ󻸷Áõ½Ä
  • atypical cystic hyperplasia
    ºñÁ¤Çü³¶¼ºÁõ½Ä
  • adenomatous hyperplasia
    »ùÁ¾°ú´ÙÇü¼º
  • adrenocortical hyperplasia
    ºÎ½Å°ÑÁú°ú´ÙÇü¼º, ºÎ½ÅÇÇÁúÁõ½Ä
  • benign lymphoid hyperplasia
    ¾ç¼º¸²ÇÁ°ú´ÙÇü¼º
  • compensatory hyperplasia
    º¸»ó°ú´ÙÇü¼º
  • complex hyperplasia
    º¹ÇÕÁõ½Ä
  • cardiac myocyte hyperplasia
    ½ÉÀå±ÙÀ°¼¼Æ÷°ú´ÙÇü¼º
  • cutaneous lymphoid hyperplasia
    ÇǺθ²ÇÁ°ú´ÙÇü¼º
  • endocervical hyperplasia
    Àڱøñ³»¸·°ú´ÙÇü¼º, Àڱðæ°ü³»¸·Áõ½ÄÁõ
  • endometrial hyperplasia
    Àڱ󻸷°ú´ÙÇü¼º, Àڱ󻸷Áõ½Ä(Áõ)
  • essential melanotic mucosal hyperplasia
    º»Å¸á¶ó´ÑÁ¡¸·Áõ½Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adenomatous hyperplasia
    »ùÁ¾°ú´ÙÇü¼º
  • adrenocortical hyperplasia
    ºÎ½Å°ÑÁú°ú´ÙÇü¼º
  • adrenogenital hyperplasia
    ºÎ½Å¼º±â°ú´ÙÇü¼º
  • angiolymphoid hyperplasia
    Ç÷°ü¸²ÇÁ±¸°ú´ÙÇü¼º
  • benign lymphoid hyperplasia
    ¾ç¼º¸²ÇÁ°ú´ÙÇü¼º
  • cardiac myocyte hyperplasia
    ½ÉÀå±ÙÀ°¼¼Æ÷°ú´ÙÇü¼º
  • compensatory hyperplasia
    º¸»ó°ú´ÙÇü¼º
  • cutaneous lymphoid hyperplasia
    ÇǺθ²ÇÁ°ú´ÙÇü¼º
  • endocervical hyperplasia
    Àڱøñ³»¸·°ú´ÙÇü¼º
  • endometrial hyperplasia
    Àڱ󻸷°ú´ÙÇü¼º, Àڱ󻸷Áõ½ÄÁõ
  • essential melanotic mucosal hyperplasia
    º»ÅÂÁ¡¸·¸á¶ó´ÑÁ¡¸·Áõ½Ä
  • fibromuscular hyperplasia
    ¼¶À¯±ÙÀ°°ú´ÙÇü¼º
  • follicular hyperplasia
    ÅÐÁý°ú´ÙÇü¼º
  • gingival hyperplasia
    ÀÕ¸öÁõ½ÄÁõ
  • glandular hyperplasia
    »ùÁ¾Áõ½Ä
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adrenal cortical insufficiency
    ºÎ½ÅÇÇÁú(±â´É)ºÎÀü(Áõ).
  • adrenal corticosteroid
    ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵å
  • adrenal corticosteroid
    ºÎ½ÅÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å.
  • adrenal corticotropic hormone =ACTH
    ºÎ½ÅÇÇÁúÀÚ±Ø(¡­ô§Ð½)È£¸£¸ó
  • adrenal crisis
    ºÎ½Å(±Þ¼º)¹ßÁõ(¡­ÐáàõÛ¡ñø). ´ç´¢ ºÎ½Å¼º À§±â.
  • adrenal crisis
    ºÎ½Å¼º À§±â(¹ßÁõ)
  • adrenal cyst
    ºÎ½Å³¶Á¾
  • adrenal disorders
    ºÎ½ÅÀå¾Ö, ºÎ½ÅÁúȯ.
  • adrenal feminism
    ºÎ½Å¼º ¿©¼ºÈ­Áõ(¡­åüàõûùñø).
  • adrenal feminization
    ºÎ½Å(¼º) ¿©¼ºÈ­(¡­åüàõûù).
  • adrenal gland
    ºÎ½Å
  • adrenal gland
    ºÎ½Å ÄáÆÏÀ§»ù
  • adrenal glucocorticoid
    ºÎ½Å±Û·çÄÚÄÚÆ¼ÄÚÀ̵å.
  • adrenal hemorrhage
    ºÎ½ÅÃâÇ÷(¡­õóúì).
  • adrenal hypertension
    ºÎ½Å¼º °íÇ÷¾ÐÁõ(¡­ÍÔúìäâñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adrenal cortex,cushings syndrome
    Äí½ÌÁõÈıº(¡­ñøý¦ÏØ)
  • adrenal cortex,hyperfunction
    ±â´ÉÇ×Áø(ÐüÒöùñòä)
  • adrenal cortex,hypofunction
    ±â´ÉÀúÇÏ(ÐüÒöî¸ù»)
  • adrenal cortical hormone =adrenocortical hormone
    ºÎ½ÅÇÇÁúÈ£¸£¸ó
  • adrenal cortical insufficiency
    ºÎ½ÅÇÇÁú(±â´É)ºÎÀü(Áõ).
  • adrenal corticosteroid
    ºÎ½ÅÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å.
  • adrenal corticosteroid
    ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵å
  • adrenal corticotropic hormone =ACTH
    ºÎ½ÅÇÇÁúÀÚ±Ø(¡­ô§Ð½)È£¸£¸ó
  • adrenal crisis
    ºÎ½Å¼º À§±â(¹ßÁõ)
  • adrenal crisis
    ºÎ½Å(±Þ¼º)¹ßÁõ(¡­ÐáàõÛ¡ñø). ´ç´¢ ºÎ½Å¼º À§±â.
  • adrenal cyst
    ºÎ½Å³¶Á¾
  • adrenal disorders
    ºÎ½ÅÀå¾Ö, ºÎ½ÅÁúȯ.
  • adrenal feminism
    ºÎ½Å¼º ¿©¼ºÈ­Áõ(¡­åüàõûùñø).
  • adrenal feminization
    ºÎ½Å(¼º) ¿©¼ºÈ­(¡­åüàõûù).
  • adrenal gland
    ºÎ½Å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
VAH vertebral ankylosing hyperostosis; Veterans Affairs Hospital; virilizing adrenal hyperplasia
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
FH facial hemihyperplasia; familial hypercholesterolemia; family history; fasting hyperbilirubinemia; f...
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
HPA axis Hypothalamic-Pituitary-Adrenal axis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ARH Adrenal regeneration hypertension
HPA Hypothalamic-Pituitary-Adrenal
HPA Hypothalamic-pituitary-adrenal axis
HPA Hypothalamo-pituitary--adrenal
HPA Hypothalamus-pituitary-adrenal
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • inflammatory hyperplasia
    ¿°Áõ¼º °úÇü¼º, ¿°Áõ¼º Áõ½Ä
    ¿°Áõ¿¡ ÀÇÇÏ¿© »ý±â´Â °úÇü¼º.
  • lentiginous melanocytic hyperplasia(ÈæÀÚ¼º ¸á¶ó´Ñ ¼¼Æ÷ Áõ½Ä)

    lentiglobus

    °ø ¸ð¾ç ¼öÁ¤Ã¼, ±¸Çü ¼öÁ¤Ã¼
    ¼öÁ¤Ã¼ Àü¸éÀÌ ±¸ÇüÀ¸·Î µÇ¾î¼­, ¼öÁ¤Ã¼ÀÇ °î¸éÀÌ °úÀåµÇ¾î º¸ÀÌ´Â °Í.
  • papillary hyperplasia
    À¯µÎ»ó Áõ½Ä, À¯µÎ Áõ½Ä
    1. ±¹¼ÒÀû ÀÚ±Ø, ºÒ·®ÇÑ ±¸°­ À§»ý, °¨¿°¿¡ ÀÇÇØ ¹ß»ýµÇ´Â »óÇÇÀÇ ´Ù¹ß¼º À¯µÎ»ó µ¹Ãâ. 2. ±¸°³ À¯µÎÁ¾ÁõÀ̶ó°íµµ ÇÑ´Ù. ÀÇÄ¡ ÇϹæ Á¡¸·¿¡ »ý±ä Ä­µð´ÙÁõÀº °æ±¸°³°¡ ÀÌ·¯ÇÑ Áõ½Ä¼º Á¶Á÷ ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ÀڱؿøÀÌ µÈ´Ù.
  • paracortical lymphoid hyperplasia
    ºÎÇÇÁú¼º ¸²ÇÁ¾ç ¼¼Æ÷ Áõ½Ä
  • perforating hyperplasia
    õ°ø¼º Áõ½Ä
  • pseudocarcinomatous hyperplasia
    °¡¼º ¾ÏÁ¾¼º Áõ½Ä
  • total hyperplasia
    Àüü °ú´Ù Çü¼º
  • adrenal
    ºÎ½ÅÀÇ, ºÎ½Å¼º, ºÎ½Å¼ºÀÇ
    ½ÅÀå ºÎ±ÙÀ̳ª À§¿¡ ÀÖ´Â. ºÎ½ÅÀÌ ¸¸µé¾î ³»´Â.
  • adrenal apoplexy
    ºÎ½ÅÁ¹Áõ, ºÎ½Å ÃâÇ÷
    ºÎ½ÅÀÇ ´ëÃâÇ÷¿¡ ÀÇÇÑ º´ÀûÀÎ »óÅ·μ­ Waterhouse-Friderichsen ÁõÈıº¿¡¼­ ³ªÅ¸³­´Ù.
  • adrenal cancer
    ºÎ½Å ¾ÏÁ¾
    ºÎ½Å ÇÇÁú Á¾¾ç¿¡´Â ¾Ëµµ½ºÅ×·ÐÁõ, Äí½Ì ÁõÈıº, ºÎ½Å ¼º±â ÁõÈıºÀÌ, ºÎ½Å ¼öÁú Á¾¾ç¿¡´Â °¥»ö ¼¼Æ÷ÁõÀÌ ÀÖ´Ù. Á¾¾ç¿¡¼­ ºÐºñµÇ´Â È£¸£¸ó¿¡ µû¶ó Áõ»óÀÌ ´Ù¸£´Ù.
  • adrenal cortex
    ºÎ½Å ÇÇÁú
    ºÎ½Å ÇÇÁúÀÇ ³»Ãø¿¡ ÀÖÀ¸¸ç À°¾ÈÀûÀ¸·Î Ȳ»öÀ¸·Î ½ÉºÎ¿¡¼­ ¼öÁú°ú Á¢ÇÏ´Â °÷Àº Ȳ°¥»öÀÌ´Ù. ÇÇÁúÀº Ç¥Ãþ¿¡¼­ ½ÉÃþÀ» ÇâÇØ¼­ ¼± ¼¼Æ÷ÀÇ ¹è¿­ ¹æ¹ýÀÌ ´Ù¸£±â ¶§¹®¿¡ ¼¼ °¡Áö zoneÀ¸·Î ³ª´¶´Ù. °¡Àå ¹Ù±ùÀº ºñ±³Àû ¾ãÀº ÃþÀÎ zona glomerulosa, °¡¿îµ¥ ÃþÀº zona fasciculata, °¡Àå ¾ÈÂÊÀº zona reticulataÀÌ´Ù. zona glomerulosa¿¡¼­ aldosteroneÀÌ ºÐºñµÇ¸ç, ºÎ½Å ÇÇÁúÀÇ Àç»ýÀ» ´ã´çÇÏ´Â ÃþÀÌ´Ù. cortisolÀº zona fasciculata¿¡¼­, dehydroe
  • adrenal cortex disease
    ºÎ½Å ÇÇÁú Áúȯ
    ºÎ½Å ÇÇÁúÀÇ ±â´ÉÀå¾Ö·Î ÀÎÇØ »ý±ä º´. ±â´É ÀúÇÏ·Î ÀÎÇØ¼­´Â ¿¡µð½¼¾¾ º´
  • adrenal cortex hyperfunction
    ºÎ½Å ÇÇÁú ±â´ÉÇ×Áø
    ºÎ½Å ÇÇÁú¿¡¼­ ºÐºñµÇ´Â ÄÚ¸£Æ¼ÄÚ ½ºÅ×·ÎÀ̵å´Â ´çÁú ÄÚ¸£Æ¼ÄÚÀ̵å, ±¤¹° ÄÚ¸£Æ¼ÄÚÀÌµå ¹× ¾Èµå·Î°Õ µî ¼¼ °¡Áö°¡ ÀÖ´Ù. µû¶ó¼­ ¼¼ °¡ÁöÀÇ µ¶Æ¯ÇÑ ºÎ½Å ÇÇÁú ±â´É Ç×Áø ÁõÈıºÀÌ ÀÖ´Ù. ÄÚÆ¼¼ÖÀÌ °úÀ× ºÐºñµÇ´Â Äí½Ì ÁõÈıº, ¾Ëµµ½ºÅ×·ÐÀÌ °úÀ× ºÐºñµÇ´Â ¾Ëµµ½ºÅ×·ÐÁõ, ºÎ½Å ¾Èµå·ÎÁ¨ÀÌ °úÀ× ºÐºñµÇ´Â ¼±Ãµ¼º ºÎ½Å Áõ½ÄÁõ µîÀÌ´Ù.
  • adrenal cortex tumor
    ºÎ½Å ÇÇÁú Á¾¾ç
  • adrenal cortical insufficiency
    ºÎ½Å ÇÇÁú ºÎÀü, ºÎ½Å ÇÇÁú ±â´ÉºÎÀü, ºÎ½Å ÇÇÁú ±â´ÉºÎÀüÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
prostatic hyperplasia Enlargement or overgrowth of the prostate gland as a result of an increase in the number of its constituent cells.
(12 Dec 1998)
pseudoepitheliomatous hyperplasia Pseudocarcinomatous hyperplasia, a benign marked increase and downgrowth of epidermal cells, observed in chronic inflammatory dermatoses; microscopically, it resembles well-differentiated squamous cell carcinoma.
(05 Mar 2000)
senile sebaceous hyperplasia Hyperplasia of mature sebaceous glands, forming a nodule on the skin of the face or forehead in elderly persons.
(05 Mar 2000)
hyperplasia <pathology> The abnormal multiplication or increase in the number of normal cells in normal arrangement in a tissue.
Compare: hypertrophy.
Origin: Gr. Plasis = formation
(18 Nov 1997)
squamous cell hyperplasia Increase in the number of cells in a squamous epithelium.
Synonym: hypertrophic dystrophy.
(05 Mar 2000)
neuronal hyperplasia Increased numbers of ganglion cells with myenteric plexus hyperplasia and increased acetylcholinesterase activity in nerves of the mucosa and submucosa. Clinically, neuronal hyperplasia mimics Hirschprung's disease. Similar findings are seen in patients with multiple endocrine neoplasia syndrome, type IIB, and in neurofibromatosis.
Synonym: hyperganglionosis, neuronal intestinal dysplasia.
(05 Mar 2000)
nodular hyperplasia of prostate Glandular and stromal hyperplasia occurring very commonly in the middle and lateral lobes of older men, forming nodules that may increasingly obstruct the urethra.
Synonym: benign prostatic hypertrophy.
(05 Mar 2000)
nodular regenerative hyperplasia A rare condition in which nodules of hyperplastic hepatocytes develop without fibrosis or general loss of lobular architecture.
Synonym: nodular regenerative hyperplasia.
(05 Mar 2000)
denture hyperplasia Overgrowth of tissue in the mucobuccal or labial fold, induced by chronic trauma from ill-fitting dentures.
Synonym: denture hyperplasia, epulis fissuratum.
(05 Mar 2000)
ductal hyperplasia Hyperplasia characterised by intraductal proliferation of epithelial cells, e.g., in the breast.
(05 Mar 2000)
idiopathic fibrous hyperplasia A condition of cystic bone growth that results from abnormal bone development. May occur with bone lesions, skin pigmentation and endocrine abnormalities.
See: McCune-Albright syndrome.
Origin: Gr. Plassein = to form
(27 Sep 1997)
inflammatory fibrous hyperplasia Overgrowth of tissue in the mucobuccal or labial fold, induced by chronic trauma from ill-fitting dentures.
Synonym: denture hyperplasia, epulis fissuratum.
(05 Mar 2000)
inflammatory papillary hyperplasia Closely arranged papules of the palatal mucosa underlying an ill-fitting denture.
Synonym: palatal papillomatosis.
(05 Mar 2000)
intravascular papillary endothelial hyperplasia A benign florid papillary endothelial proliferation within the veins of the skin or subcutis, less often in visceral blood vessels.
Synonym: Masson's pseudoangiosarcoma.
(05 Mar 2000)
thymus hyperplasia Enlargement of the thymus. A condition described in the late 1940's and 1950's as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á